Horizon Kinetics Asset Management »

Relmada Therapeutics shares owned by Horizon Kinetics Asset Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Horizon Kinetics Asset Management from 13F filings

Historical chart of Horizon Kinetics Asset Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Horizon Kinetics Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Horizon Kinetics Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $124k 30k 4.14

More positions owned by Horizon Kinetics Asset Management

Texas Pacific Land Corp (TPL)
Grayscale Bitcoin Trust Btc Trust Btc (GBTC)
Wheaton Precious Metals Corp (WPM)
Caci Intl Inc Cl A Cl A (CACI)
Intercontinental Exchange (ICE)
Franco-Nevada Corporation (FNV)
Civeo Corp Com New (CVEO)
Cheniere Energy Com New (Principal) (LNG)
CBOE Holdings (CBOE)
Mesabi Tr Ctf Ben Int (MSB)
Science App Int'l (SAIC)
Brookfield Corp Cl A Lmt Vtg S Cl A Ltd Vt Sh (BN)
Permian Basin Rty Tr Unit Ben Int (PBT)
Archer Daniels Midland Company (ADM)
Howard Hughes Holdings (HHH)

View all positions for Horizon Kinetics Asset Management

Top funds holding Relmada Therapeutics

Vanguard Group
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Citadel Advisors
Two Sigma Advisers
Two Sigma Investments
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Bank of America Corporation
Millennium Management
Guild Investment Management
Marshall Wace
Barclays

View all funds holding Relmada Therapeutics